ALNOV:EPA
Novacyt SA
0,44 €
0,00%
(0,00) 1D
19 ნოე, 17:35:19 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,44 €
High
0,45 €
Low
0,44 €
Mkt. cap
33,30 მლნ.
Avg. vol.
136,90 ათ.
Volume
0,00
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
37,66 მლნ.
No. of employees
228
Open
0,44 €
High
0,45 €
Low
0,44 €
Mkt. cap
33,30 მლნ.
Avg. vol.
136,90 ათ.
Volume
0,00
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
37,66 მლნ.
No. of employees
228
News stories
From web sources and news partners
FOREX.com
·
6 საათის წინ
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
FXStreet
·
7 საათის წინ
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Traders Union
·
7 საათის წინ
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
·
4 საათის წინ
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEOდავიდ ალმონდ
Employees228
Founded3 ივლ. 2006
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com